ORIGINAL ARTICLE |
|
Year : 2019 | Volume
: 2
| Issue : 3 | Page : 58-62 |
|
Complete mesocolic excision for colon cancer
Puvvala Sriphani1, Kotagiri Sreekanth1, Gogineni Tarun Chowdary1, Vasureddy Challa1, Ajay Chanakya Vallabhaneni1, Deepak Yadlapalli2
1 Department of Surgical Oncology, GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India 2 Department of Medical Oncology, GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India
Correspondence Address:
Dr. Puvvala Sriphani Department of Surgical Oncology, GSL Medical College and General Hospital, NH 16, Lakshmi Puram, Rajahmundry, Andhra Pradesh India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/IJCS.IJCS_24_20
|
|
Background: The aim of the present study was to define the complete mesocolic excision (CME) in conjunction with central vascular ligation (CVL) as the defined surgical treatment for colon cancer. Methods: A prospective study was conducted between August 2014 and August 2017, at GSL Medical College and General Hospital. A total of 46 patients (31 cases in open and 15 in the laparoscopic arm) demographic data, operative details, and postoperative outcomes, follow-up, the pathologic results were reviewed. Results: All patients (n = 46) underwent an elective CME + CVL for colon cancer. The mean age of patients was 57.8 ± 16.6 years. Of the 46, 28 were male, and 18 were female. The mean operation time was 61.2 ± 155.2 min. The mean blood loss was 88.6 ml. The mean number of total harvested lymph nodes was 28.6. The mean length of the hospital stay was 12.9 days. Conclusion: Based on the data presented in this study, CME with CVL is a feasible and safe procedure for treating colon cancer. Although the present study had certain limitations, like its small study, patients from a single center, CME with CVL was found to lead to better oncological outcomes for the colon surgery. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|